Boston Scientific (BSX) Revenue — Quarter Ended Dec 31, 2024
Revenue increased in the reporting quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue increased in the reporting quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$4.6B
Revenue reported for this quarter.
Quarter-over-quarter
+8.4%
Change from the immediately preceding quarter.
Year-over-year
+22.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$16.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $3.9B | +13.8% |
| Jun 30, 2024 | $4.1B | +14.5% |
| Sep 30, 2024 | $4.2B | +19.3% |
| Dec 31, 2024 | $4.6B | +22.4% |
Revenue performance
The reported revenue reflects a sequential increase from the immediately preceding quarter. On a year-over-year basis, revenue growth was also positive.
Quarterly comparison
Compared to the prior quarter, revenue moved higher. Relative to the same quarter in the prior year, revenue also showed an increase.
What to watch
The filing notes restructuring charges and litigation-related net credits in prior periods, which may affect future comparability.